New Drug Approvals: “Human Organ-on-a-Chip” GAO Report Supports Innovation and Regulatory Policy for Non-Animal Models

Animal models remain foundational to biomedical research, having contributed to the development of vaccines, drugs, and surgical innovations. But their continued use faces growing scrutiny due to ethical concerns, species-specific physiological differences that limit the predictive power of animal models for human disease, and high costs….
By: Foley & Lardner LLP